Awards

METASTCURE colon cancer therapeutic project receives the Seal of Excellence recognition from the EU H2020 Programme

November 25th, 2020 PROALT’s project proposal named ‘METASTCURE – Anti cadherin-RGD monoclonal antibody PA-0661 for the treatment of metastatic colorectal cancer’ has received the Seal of Excellence recognition from the Enhanced European Innovation Council (EIC) pilot in EU. The EIC Accelerator programme is part of the Enhanced European Innovation Council pilot and provides grant and blended [...]

2020-11-27T14:44:08+00:0025 November 2020|Tags: , , , , |

PROALT, nominated for the Innovation Award, presents ColoDetect in MEDICA

Photo: Dr. Juan I. Imbaud during its presentation. 14th, November 2017 PROALT was nominated for the Innovation Award and presented its colorectal cancer diagnostic and therapeutic projects at the eHealth Venture Summit 2017 in November 14th. The competition took place as part of MEDICA HEALTH FORUM in Düsseldorf (Germany) from 13-16 November. The eHealth Venture [...]

2020-05-05T15:33:34+00:0014 November 2017|Tags: , , |

PROALT has been selected finalist in ‘The South Summit 2014’ startups competition

October 10th, 2014Protein Alternatives has been finalist in 'The South Summit' 2014. The company was selected within the 100 finalists from more than 3000 startups from Southern Europe and South America, and participated in the new global start up hub event THE SOUTH SUMMIT 2014 on October 8-10. COLODETECT, un proyecto presentado por la empresa [...]

2020-05-05T15:38:11+00:0010 October 2014|Tags: , , , |
Go to Top